Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $33.84 + 0.08
August 18, 20174:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q2 2017 Investor Presentation

Annual Reports

Download Documentation 2016 Annual Report to Stockholders

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Systems Technology, Inc. Reports Second Quarter 2017 Financial Results; Updates 2017 Outlook

August 7, 2017

Q2 Revenue Increase of 33% Year-over-Year; Revenue Up 38% Year-to-Date MINNEAPOLIS, Aug. 07, 2017 ... 

Read More >

Tactile Medical Announces Appointment of Cheryl Pegus to Board of Directors

August 1, 2017

MINNEAPOLIS, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”... 

Read More >

Upcoming Events

There are currently no events scheduled.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet